Evidence map›Paper›PMID 41551370›Full record

ArticleNeurology. Genetics2026

Autosomal Dominant

Jasmijn Annemiek Hebbink, Jikke-Mien F Niermeijer, Elene Vroegindeweij, Bert B A de Vries, Sjoert Pegge, Erik-Jan Kamsteeg, Michel A A P Willemsen

Abstract read
In one paragraph

Article in Neurology. Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Introducing a novel variant in the FTH1 gene; A closer look at FTH1-related neuroferritinopathy as a neurodegeneration with brain iron accumulation (NBIA) disorder.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jasmijn Annemiek HebbinkNeurology, Radboudumc, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0001-6968-3100
Jikke-Mien F NiermeijerPaediatric Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.ORCID https://orcid.org/0009-0006-1244-6132
Elene VroegindeweijNeurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.ORCID https://orcid.org/0000-0002-1161-4521
Bert B A de VriesClinical Genetics, Radboudumc, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-0000-2917
Sjoert PeggeRadiology, Radboudumc, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0001-9314-6137
Erik-Jan KamsteegHuman Genetics, Radboudumc, Nijmegen, the Netherlands; and.ORCID https://orcid.org/0000-0001-6480-1892
Michel A A P WillemsenPaediatric Neurology, Amalia Children's Hospital Radboudumc, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0001-7860-7791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We report on a patient with a distinct clinical and neuroradiologic phenotype and a de novo variant in the Methods: The patient was a 25-year-old woman with developmental delay and pontocerebellar hypoplasia, who after years of stable condition visited our hospital at age 20 years because of clinical deterioration. With consent from the patients' family, we obtained clinical, imaging, and genetic data from the patient's medical record. Results: Neurologic examination demonstrated a new hypertonia, ataxia, dystonia, dysarthria, and apathy. Cerebral MRI revealed new bilateral symmetrical signal abnormalities of the basal nuclei, thalamus, cerebral peduncles, and hippocampus, indicating iron accumulation. Exome sequencing revealed a de novo monoallelic variant in the Discussion: Similar de novo

Identifiers

PMID41551370
PMCPMC12807490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.